Medline Inc.
For the period ended Jun 27, 2026. Filed Aug 5, 2026.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Jun 27, 2026 · Filed Aug 5, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Item 5. Other Information
Trading Plan Arrangements
The table below summarizes the terms of trading arrangements adopted orterminated by our officers or directors during the three months ended June 27, 2026. The trading arrangement listed below is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).
| Name | Title | Date of Adoption or Termination | Duration of Trading Arrangement | Number of Shares to be Sold Pursuant to the Trading Arrangement* |
|---|---|---|---|---|
| William J. Abrams | Executive Vice President, Supply Chain Solutions | Adopted on May 26, 2026 | November 12, 2026 – March 31, 2027 | Up to 1,139,433 shares of Class A common stock |
- Represents the maximum number of shares that may be sold pursuant to the trading arrangement. The actual number of shares sold will depend upon the satisfaction of certain conditions as set forth in the written plan.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.